Category: erroneous data

Authors pull malaria study after arguing over the results

journal-of-advanced-pharmaceutical-technology-researchResearchers have retracted a study about malaria infections in India after follow-up research unveiled problems with the data and set off a dispute among the authors.

According to the notice, when the authors continued their research on the same topic, some of the new data raised concerns about what was reported in the 2010 paper. That set off a “number of disputes between authors,” which led them to retract the paper.

This account was supported by the study’s first and corresponding author, Naitik Trivedi, from the A.R. College of Pharmacy & G.H. Patel Institute of Pharmacy in Anand, Gujarat, India. Trivedi told us he believes the previous study didn’t include some relevant parameters, which affected the results. 

Trivedi noted that all the authors agree to the retraction, adding: Continue reading Authors pull malaria study after arguing over the results

Despite retraction, antipsychotics still effective, safe for dementia, says author

alzheimers-research-and-therapyResearchers have retracted a systematic review that suggested that antipsychotic drugs are effective and safe for patients with symptoms of dementia — but claim their re-analysis of the updated data still comes to the same conclusions.

According to the retraction notice in Alzheimer’s Research and Therapy, some participants were incorrectly included twice in the meta-analysis. 

The corresponding authors recently lost another paper for an entirely different reason — earlier this year, we reported on a retraction in Annals of Neurology for Jin-Tai Yu and Lan Tan, affiliated with the Ocean University of China, Qingdao University, and Nanjing Medical University in China. The authors pulled that paper after appearing to pass off others’ data as their own.

Here’s the retraction notice for the review, issued earlier this year: Continue reading Despite retraction, antipsychotics still effective, safe for dementia, says author

Authors retract (and replace) cardiac rehab study in JAMA journal

jama-internal-medicine

Researchers have retracted and replaced a 2014 paper in JAMA Internal Medicine after realizing a number of errors had affected the findings.

The authors note the mistakes do not have a significant impact on the overall proportion of heart patients who participated in cardiac rehab. However, a number of findings were affected, such as the difference in participation in cardiac rehab defined by race, and how the overall participation has changed throughout the years.

Therefore, JAMA Internal Medicine has published a lengthy notice of retraction and replacement, which explains the errors made in the original paper, and updated the first paper with a new version of the study.

The retraction and replacement notice, issued this week, starts: Continue reading Authors retract (and replace) cardiac rehab study in JAMA journal

Costly genotyping mistake forces lab to pull 3rd paper

KPSB_11_09_COVER.inddA few months ago, an author alerted us to two retractions — including one in PNAS — after realizing his team had been using plants affected by inadvertent genotyping errors for an entire year. He initially told us these were the only two papers affected, but more recently reached out to say he had to pull a follow-up article, as well.

Recently, Steven C. Huber contacted us about the newest retraction, noting he was submitting a notice to the editor of Plant Signaling and Behavior:

Continue reading Costly genotyping mistake forces lab to pull 3rd paper

Child psychiatrist flagged for misconduct loses two more papers

Mani PavuluriA child psychiatrist has lost two papers after an institutional investigation concluded that she intentionally misrepresented children’s medication history in her research.

In November 2015, we reported on a retraction for Mani Pavuluri in the Journal of Psychiatry & Neuroscience following a probe at the University of Illinois at Chicago, her institution, which concluded that there was a “preponderance of evidence” that Pavuluri had committed misconduct. 

After an “unanticipated event” took place during a study, three studies by Pavuluri were halted and a letter was sent out to 350 research subjects, informing them of errors in the work. At the time, the Illinois spokesperson noted that Pavuluri — who, according to her LinkedIn page, is a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry — was also asked to retract two 2013 studies in the Journal of Affective Disorders. Those papers have now been retracted, noting that Pavuluri “intentionally and knowingly” misrepresented children’s medication history.

Here’s the retraction notice for “Deficits in emotion recognition in pediatric bipolar disorder: The mediating effects of irritability:” Continue reading Child psychiatrist flagged for misconduct loses two more papers

Oh, well — “love hormone” doesn’t reduce psychiatric symptoms, say researchers in request to retract

psychiatry-research

It turns out, snorting the so-called “love hormone” may not help reduce psychiatric symptoms such as depression and anxiety.

At least, that’s the conclusion the authors of a 2015 meta-analysis, which initially found intranasal doses of oxytocin could reduce psychiatric symptoms, have now reached. After a pair of graduate students pointed out flaws in the paper, the authors realized they’d made some significant errors, and oxytocin shows no more benefit than placebo.

First author Stefan Hofmann from Boston University in Massachusetts explains further in a lengthy letter he sent to Psychiatry Research, which he passed on to us: Continue reading Oh, well — “love hormone” doesn’t reduce psychiatric symptoms, say researchers in request to retract

Does dose matter? Tumor killer paper thought so, now must retract

Molecular Medicine ReportsAfter questions from a reader, researchers took a second look at their data about the effects of a vitamin A metabolite on tumor cells, and realized their key finding was inaccurate.

They’re now retracting the paper, from Molecular Medicine Reports, because it originally reported that higher concentrations of retinoic acid (RA) were more effective in curbing the proliferation of brain tumor cells. But it seems that the RA dose made less of a difference than they originally believed, according to the retraction notice:

Continue reading Does dose matter? Tumor killer paper thought so, now must retract

Where was chem research conducted? Not here, say two of three listed author affiliations

ChemosphereA researcher has retracted two 2016 papers after discovering problems with the data that negated the findings — and after one of his three listed affiliations denied the research was conducted there.

According to the retraction notices issued by Chemosphere, Hong-Wei Luo incorrectly claimed to be affiliated with the Oak Ridge National Laboratory (ORNL) in Tennessee in one of his three affiliations. His other institutions listed on the papers include universities in Singapore and China.

However, an official from the Nanyang Technological University (NTU) in Singapore, told us the work in the now-retracted papers was not carried out at the NTU either.

Here’s the first of the retraction notices, issued on August 8: Continue reading Where was chem research conducted? Not here, say two of three listed author affiliations

Doing the right thing: Authors pull psych review after finding inaccuracies

Two psychology researchers are retracting a meta-analysis after discovering errors they believe may affect the conclusions.

We’re giving this a “doing the right thing” nod, as last author Pankaj Patel of Villanova University in Pennsylvania contacted us about his plan to retract the paper, and resubmit for publication once he and co-author Sherry Thatcher — at the University of South Carolina — have performed all their recalculations.

Here’s the retraction notice for “Demographic faultlines: A meta-analysis of the literature,” published in the Journal of Applied Psychology: Continue reading Doing the right thing: Authors pull psych review after finding inaccuracies

Second retraction for bone researcher with lifetime funding ban

via WCH
via WCH

A researcher banned from funding by a Canadian agency for misconduct has earned her second retraction, after a reanalysis uncovered problems with the paper’s conclusions.

The retraction follows an investigation by Sophie Jamal‘s former workplace, the Women’s College Hospital in Toronto, which has led to a recent retraction of a JAMA paper due to data manipulation, and a lifetime funding ban from the Canadian Institutes of Health Research (CIHR).

The latest retraction stemmed from a re-analysis of the paper by the Canadian Multicentre Osteoporosis Study Group, of which the paper was a part; all authors but Jamal have requested the retraction. In the notice, the authors say that they believe no patients were harmed as a result of the “possibly invalid conclusions” in the paper, which showed patients with kidney problems were at higher risk of bone loss. A researcher told us a third paper by Jamal is also due to be retracted soon.

Here’s the retraction notice, issued by the American Journal of Kidney Diseases (AJKD): Continue reading Second retraction for bone researcher with lifetime funding ban